| Literature DB >> 31752843 |
Manuel Leonard F Albis1, Subrata K Bhadra2, Brian Chin3.
Abstract
BACKGROUND: The Urban Primary Health Care Project (UPHCP) was implemented by the Government of Bangladesh in response to rapid urbanization and growing inequalities in access to and quality of primary health care. The goal of the project was to improve health status of the urban poor living in city corporations and municipalities through the provision of health care services by NGOs that are contracted through public-private partnership. The first phase of the project started in 1998 and the project is currently in its fourth phase covering more urban areas than the first three phases. This study evaluates the impact of the second phase project (UPHCP-II) on health outcomes, mainly child diarrhea, acute respiratory infection, antenatal and postnatal care, skilled birth attendance, breastfeeding prevalence, contraceptive prevalence, sexually transmitted infections, and HIV/AIDS awareness.Entities:
Keywords: Bangladesh; Contracting; Impact evaluation; Maternal and child health; Primary health care; Propensity score matching; UPHCP-II; Urban health
Mesh:
Year: 2019 PMID: 31752843 PMCID: PMC6956513 DOI: 10.1186/s12913-019-4406-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Sample Map of Dhaka City Corporation Showing Project and Non-Project Areas. Note: PA – project area; NPA – non-project area; 10 wards of Dhaka City Corporation in 2012 shown. Source: Authors’ own figure
Fig. 2Recalibration of Baseline Survey Sampling Weights
Number of Individuals Per Area After Matching Sampling Designs
| Area | Baseline | Endline | ||
|---|---|---|---|---|
| Project Area | Non-project Area | Project Area | Non-project Area | |
| Dhaka | 2046 | 1769 | 3314 | 3320 |
| Khulna | 798 | 794 | 711 | 707 |
| Rajshahi | 551 | 349 | 746 | 711 |
| Barisal | 398 | 215 | 347 | 341 |
| Sylhet | 299 | 234 | 363 | 387 |
| Chittagong | 3434 | 334 | 1092 | 1143 |
| Comilla | 61 | 28 | 375 | 373 |
| Municipalities | 93 | 182 | 2490 | 2622 |
| Total | 7680 | 3905 | 9438 | 9604 |
Fig. 3Trends of Child Mortality Rates in Project Areas
Fig. 4Child Nutrition in Project Areas
Fig. 5Childhood Diarrhea and ARI Prevalence in Project Areas
Project Impact on Diarrhea, ARI and Fever Prevalence
| Health Indicator | ATT | Bootstrap SE | 95% CI | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Diarrhea Prevalence | −3.6 | *** | 0.9 | −5.3 | −1.9 |
| ARI Prevalence | −2.7 | ** | 1.3 | −5.2 | −0.3 |
| Fever Prevalence | −4.1 | ** | 2.0 | −8.1 | −0.2 |
| ARI and Fever Prevalence | −4.9 | *** | 1.1 | −7.1 | −2.7 |
Legend: ** Significant at 5%; *** Significant at 1%
Fig. 6ANC, PNC and Skilled Birth Attendance in Project Areas
Project Impact on ANC, PNC and Skilled Birth Attendance
| Health Indicator | ATT | Bootstrap SE | 95% CI | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| ANC Coverage (at least 1 visit) | 3.3 | 2.1 | −0.8 | 7.4 | |
| ANC Coverage (at least 2 visits) | 2.7 | 2.3 | −1.9 | 7.3 | |
| ANC Coverage (at least 3 visits) | 4.2 | * | 2.5 | −0.8 | 9.1 |
| PNC Coverage - All mothers who gave birth within 5 years preceding the survey | −1.8 | 2.4 | −6.6 | 2.9 | |
| Skilled Birth Attendance | 1.9 | 2.4 | −2.8 | 6.6 | |
Notes: Last Born Child only
Legend: * Significant at 10%
Fig. 7Breastfeeding Rates in Project Areas
Project Impact on Breastfeeding
| Health Indicator | ATT | Bootstrap SE | 95% CI | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Ever Breastfed | −3.4 | *** | 1.3 | −6.0 | −0.9 |
| Breastfed within 1 day of birth | 2.3 | 2.8 | −3.1 | 7.7 | |
Notes: Last Born Child only
Legend: *** Significant at 1%
Fig. 8Contraceptive Prevalence Rate and HIV/AIDS Awareness in Project Areas
Contraceptive Prevalence, STI Prevalence and HIV/AIDS Awareness
| Health Indicator | ATT | Bootstrap SE | 95% CI | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Contraceptive Prevalence (married women) | 4.5 | *** | 1.3 | 2.0 | 7.0 |
| STI Prevalence (women) | −2.1 | ** | 1.0 | −4.0 | −0.2 |
| HIV/AIDS Awareness | 2.4 | *** | 0.6 | 1.2 | 3.7 |
| HIV/AIDS Avoidance | 2.2 | ** | 1.0 | 0.2 | 4.3 |
Legend: ** Significant at 5%; *** Significant at 1%